Application 207323
- Type
- ANDA
- Sponsor
- GLAND PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CISPLATIN | CISPLATIN | INJECTABLE;INJECTION | 1MG/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 47781-609 | Cisplatin | cisplatin | Alvogen Inc. | ANDA | Current |
| 47781-609 | Cisplatin | cisplatin | Alvogen Inc. | ANDA | Current |
| 47781-610 | Cisplatin | cisplatin | Alvogen Inc. | ANDA | Current |
| 47781-610 | Cisplatin | cisplatin | Alvogen Inc. | ANDA | Current |
| 68083-162 | CISPLATIN | Cisplatin | Gland Pharma Limited | ANDA | Current |
| 68083-163 | CISPLATIN | Cisplatin | Gland Pharma Limited | ANDA | Current |
| 70860-206 | Cisplatin | cisplatin | Athenex Pharmaceutical Division, LLC. | ANDA | Current |